Due to increasing market share in the space, coupled with more awareness on its games, shares in the company made their debut ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics carries out ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that BioArctic's founder, Professor Lars Lannfelt, will receive the 2025 ...

Shares in Hacksaw began trading on Nasdaq Stockholm after the supplier completed an oversubscribed initial public offering ...

Shares in Hacksaw, the Swedish online gambling company, jumped 11% early on its first day of trading on Nasdaq Stockholm on ...

Cloetta AB is a buy right now, supported by positive momentum, rising profitability, and a clear strategic direction toward ...

Johan Löf, founder and CEO, RaySearch: "RayCare v2025 reflects our unwavering commitment to advancing integrated, intelligent cancer care. With every release, we take another step towards a future ...

Xspray Pharma AB (publ) today announces that the U.S. Food and Drug Administration (FDA) has conducted a successful Pre-Approval Inspection (PAI) of the company's manufacturing lines, located at a con ...

FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation ...

STOCKHOLM, SE / ACCESS Newswire / June 27, 2025 / iZafe Group (STO:IZAFE-B.ST) ("iZafe" or the "Company") announces today that the Board of Directors has resolved, based on the authorization granted ...

Mutares is planning to list its portfolio company Terranor Group through a public offering on Nasdaq First North Growth ...

Fingerprint Cards is making changes to it leadership as it continues a transition from specializing in biometric sensors to ...